300760.SZ
迈瑞医疗
SZSE · Healthcare · C 制造业 · CN
CNY 158.68
+2.74%Year over year
Reported trailing growth
- Revenue
- -6.2%
- EBITDA
- —
- EBIT
- -26.3%
- EPS
- -29.7%
- Free cash flow
- -12.4%
- Operating cash flow
- -9.3%
Forward estimates
Based on analyst estimates
- Revenue
- +17.4%
- EBITDA
- +8.9%
- EPS
- +16.9%
Three-year CAGR
- Revenue
- +3.1%
- EBITDA
- -1.1%
- EBIT
- -3.8%
- Net income
- -5.4%
- EPS
- -5.4%
- Free cash flow
- -7.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026